Fate Therapeutics Inc. Common Stock

REPLAY BUTTONS

∣‹ ‹‹ ∥ › ›› ›∣

POSITION	OPEN	PROFIT	P & L
LONG
SHORT

Fate Therapeutics Inc. Common Stock. Replay the stock market charts of FATE day by day, back to 2003. Open long and short positions without spending any money. Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.

FATE Daily Chart

FATE Options Chain

Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program - Fate Therapeutics ( NASDAQ:FATE )
May 9, 2024
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting - Fate Therapeutics ( NASDAQ:FATE )
May 3, 2024
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
May 3, 2024
Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
April 22, 2024
Novartis ( NVS ) to Report Q1 Earnings: What to Expect?
April 19, 2024
Fate Therapeutics ( FATE ) Surges 86.4% YTD on Pipeline Progress
April 6, 2024
Why Is Amicus Therapeutics ( FOLD ) Down 8.1% Since Last Earnings Report?
March 29, 2024
Why Is Myriad ( MYGN ) Down 1% Since Last Earnings Report?
March 28, 2024
Fate Therapeutics ( FATE ) Down 8% Since Last Earnings Report: Can It Rebound?
March 27, 2024
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement - Fate Therapeutics ( NASDAQ:FATE )
March 19, 2024

FATE Free Cash Flow

FATE Income Statement

FATE Stock Price vs Net Income

FATE Financial Reports